Code Bio

Code Bio’s novel synthetic DNA delivery platform, 3DNA^®, is designed to unlock fully the potential of genetic medicines by overcoming challenges inherent to viral-based delivery, such as immunogenicity, gene size and delivery limitations, ability to re-dose, and manufacturing complexity. Code Bio is advancing an internal pipeline of transformative therapies with the potential to treat multiple serious and life-threatening diseases, both rare and prevalent.